Novo Nordisks subcutaneous and oral amycretin data published in The Lancet and presented at ADA 2025
Subcutaneous amycretin phase 1b/2a data on the safety, tolerability and weight loss…
MSCI Announces the Results of the MSCI 2025 Global Market Accessibility Review
NEW YORK--(BUSINESS WIRE)--MSCI Inc. (NYSE: MSCI), a leading provider of critical decision…
New Global Aesthetics Report: A Shift Towards Facial Surgery Globally as Eyelid Ranks Top Procedure
Aesthetic Procedures Close to 38 Million in 2024. MOUNT ROYAL, N.J., June 20,…
Rockefeller Foundation and The Bridgespan Group Collaborate to Catalyze High-Impact Philanthropy across Asia
New USD $100,000 grant supports the Bridgespan-led Funders Council's efforts to help…
Addex Therapeutics to Release Q1 2025 Financial Results and Host Conference Call on June 19, 2025
June 18, 2025 01:00 ET Â | Source: Addex Therapeutics Geneva, Switzerland, June…
EHA 2025 | Multiple Studies Report Encouraging Data of Olverembatinib in Ph+ ALL
ROCKVILLE, Md. and SUZHOU, China, June 15, 2025 (GLOBE NEWSWIRE) -- Ascentage…
![Real IQ Test Online | Quick IQ Test with Instant Results [Accurate & Legit] Special 2025 Announcement](https://i0.wp.com/ml.globenewswire.com/Resource/Download/43db9f2e-a3be-4ca2-89e5-2abb41f352d8?w=420&resize=420,280&ssl=1 "Real IQ Test Online | Quick IQ Test with Instant Results [Accurate & Legit] Special 2025 Announcement")
Real IQ Test Online | Quick IQ Test with Instant Results [Accurate & Legit] Special 2025 Announcement
San Francisco, CA, June 13, 2025 (GLOBE NEWSWIRE) -- Â Quick IQ Test…
Genmab Announces Epcoritamab Investigational Combination Therapy Demonstrates High Response Rates in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Eligible for Autologous Stem Cell Transplantation (ASCT)
Media ReleaseCOPENHAGEN, Denmark; June 15, 2025 Results from the EPCORE® NHL-2 trial…
Investigational combination of first-in-class bispecific antibodies TALVEY (talquetamab) and TECVAYLI (teclistamab) shows deep and durable responses in heavily pretreated multiple myeloma patients with extramedullary disease
Results from the Phase 2 RedirecTT-1 study demonstrate deep responses with 78.9…
Monolithic Power Systems Announces Second Quarter 2025 Dividend
June 13, 2025 16:01 ET Â | Source: Monolithic Power Systems, Inc. KIRKLAND,…